EB 144 IFPMA statement under agenda item 5.7, Access to Medicines and Vaccines Roadmap
WIPO and IFPMA Launch New Online Patent-Search Resource to Help Health Agencies Procure Medicines
AMR Position Papers
Better Health Partnerships Across Africa
R&D Pipeline for Tuberculosis
IFPMA 2017 Interview Series: Experts take on 9th Asia Regulatory Conference
IFPMA Statement on UHC at 67th Session of the WHO Regional Committee for Africa
WHA70 IFPMA Reception Speakers' Quote
IFPMA Position on Convergence of Good Manufacturing Practice (GMP) standards and Related Inspections
IFPMA contribution to key global health discussions @WHA70 (22-31 May 2017)
WHO WHA 70 agenda item 15.2 Draft global action plan on the public health response to dementia
WHO WHA 70 item 13.6 Member State mechanism on SSFFC
WHO WHA 70 Item A70/12 Antimicrobial resistance
IFPMA and IAEA - VUCC Virtual University for Cancer Control
New Alliance to Drive and Measure Industry Progress to Curb Antimicrobial Resistance
IFPMA highlight: From shortages to sustainable supply
Geneva Pharma Forum on medicines and vaccines shortages 28 April 2017-edited version
Geneva Pharma Forum on medicines and vaccines shortages 28 April 2017-live event
IFPMA recommends WHO Fair Pricing Forum outcomes focus on feasible areas for collaboration where there is broad consensus
Fumie Griego joins International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as new Assistant Director General
Progress report on biopharmaceutical industry contributions to the global fight against Neglected Tropical Diseases (NTDs)
R&D Pipeline for EBOLA
R&D Pipeline for MALARIA
Delivered at the 21st WHO Expert Committee on the Selection and Use of Essential Medicines
Taking a Leap Toward Global Supply Chain Efficiency - Part II
5 Ways to Getting the Supply Chain in Sync
IFPMA launches new policy principles and report on Rare Disease Day 2017 to benefit patients, healthcare and society
A set of policy principles to meet the global challenge of Rare Diseases
Rare Diseases: shaping a future with no-one left behind
G-FINDER Report 2016: The biopharmaceutical industry confirms its status as a significant funder of neglected disease R&D
1 2 3 12

Other Tags

Access Access to antiretrovirals Access to Medicines Access to vaccines Africa AMR AMR Industry Alliance Anti-Counterfeit Antibiotics antimicrobial resistance Assembly Biosimilars Biotherapeutic Medicines Biotherapeutics Cancer Code of Practice collaboration Counterfeit Medicines Counterfeits Developing World Donations Economic footprint Efficacy Ethics; Code; Business integrity; Compliance Event Highlights Fake Medicines Fakes Fight the Fakes Flu Global Health harmonization Health Health Partnerships HIV/AIDS IFPMA IFPMA Assembly IFPMA Geneva Pharma Forum IFPMA Statement Immunization Incremental Innovation Influenza Influenza Vaccination Infographic Infographics Innovation Innovation ecosystem IP IVS Latin America Latin America Conference Malaria MDGs Medicines Mental and Neurological Disorders Millennium Development Goals NCD NCDs Neglected Tropical Diseases News Releases Non-Communicable Diseases NTDs Pandemic Influenza Pandemic preparedness partnership Partnerships Pharma Pharmacovigilance Position Paper Prevention PSI Publications Public Health Quality R&D Regulatory regulatory systems Regulatory System Strengthening Related Links Research Safety SDGs Seasonal Influenza Statements Supply chain Sustainable Development Goals Sustainable Innovation trade Treatments Tuberculosis UHC Universal Health Coverage Vaccine Vaccines Vaccine Supply Value of Innovation Videos WHA WHO WIPO Women’s Cancers